73: Preoperative and Intraoperative Features Associated with Positive Lymph Nodes During Nephrectomy for Renal Cell Carcinoma

2006 ◽  
Vol 175 (4S) ◽  
pp. 24-25
Author(s):  
R. Houston Thompson ◽  
Christine M. Lohse ◽  
Igor Frank ◽  
Horst Zincke ◽  
Michael L. Blute ◽  
...  
2013 ◽  
Vol 137 (11) ◽  
pp. 1584-1590 ◽  
Author(s):  
Vikas Mehta ◽  
Kumaran Mudaliar ◽  
Ritu Ghai ◽  
Marcus L. Quek ◽  
John Milner ◽  
...  

Context.—Despite decades of research, the role of lymphadenectomy in the management of renal cell carcinoma (RCC) is still not clearly defined. Before the implementation of targeted therapies, lymph node metastases were considered to be a portent of markedly decreased survival, regardless of the tumor stage. However, the role of lymphadenectomy and the relative benefit of retroperitoneal lymph node dissection in the context of modern adjunctive therapies have not been conclusively addressed in the clinical literature. The current pathologic literature does not offer clear recommendations with regard to the minimum number of lymph nodes that should be examined in order to accurately stage the pN in renal cell carcinoma. Although gross examination of the hilar fat to assess the nodal status is performed routinely, it has not yet been determined whether this approach is adequate. Objective.—To evaluate the status of lymph nodes and their rate of identification in the pathologic examination of nephrectomy specimens in adult renal malignancies. Design.—We reviewed the operative and pathology reports of 871 patients with renal malignancies treated by nephrectomy. All tumors were classified according to the seventh edition of the Tumor-Nodes-Metastasis classification. Patients were divided into 3 groups: Nx, no lymph nodes recovered; N0, negative; and N1, with positive lymph nodes. Grossly visible lymph nodes were submitted separately; as per grossing protocol, hilar fatty tissue was submitted for microscopic examination. We evaluated the factors that affected the number of lymph nodes identified and the variables that allowed the prediction of nodal involvement. Results.—Lymph nodes were recovered in 333 of 871 patients (38%): hilar in 125 patients, nonhilar in 137 patients, and hilar and nonhilar in 71 patients. Patients with positive lymph nodes (n = 87) were younger, had larger primary tumors, and had lymph nodes of average size, as well as a higher pT stage, nuclear grade, and rate of metastases. Metastases were seen only in grossly identified lymph nodes (65% hilar, 16% nonhilar); all microscopic nodes were negative. Even with the microscopic examination of fat, hilar lymph nodes were recovered in only 22.5% of patients. A nonhilar route of node metastasis was suspected in 40 patients. Conclusions.—Only grossly identifiable lymph nodes, both hilar and nonhilar, were positive for metastases. Although microscopic examination of the hilar fat increased the number of lymph nodes recovered, the identification rate of these nodes was low (22.5%), and such microscopic nodes were invariably negative. Hence, microscopic examination of the hilar fat may be unnecessary.


2021 ◽  
pp. 1-9
Author(s):  
Ruotao Xiao ◽  
Chuxiao Xu ◽  
Liyuan Ge ◽  
Wei He ◽  
Bin Yang ◽  
...  

<b><i>Introductions:</i></b> The objective of this study was to determine the prognostic value of positive lymph nodes (LNs) in patients with renal cell carcinoma (RCC) and tumor thrombus (TT) and to explore risk factors predicting LNs metastasis. <b><i>Methods:</i></b> We retrospectively analyzed 216 patients with RCC and TT treated at a single institution from January 2015 to December 2019. Overall survival (OS) and progression-free survival (PFS) was estimated using the Kaplan-Meier curves divided by pathological LN status. Associations between clinicopathological features and survival outcomes were evaluated using Cox regression models. Logistic regression model was performed to determine risk factors associated with LN metastasis. <b><i>Results:</i></b> We identified 216 patients with RCC and TT including 85 (39.4%) who did and 131 (60.6%) who did not undergo lymph node dissection. Pathologically positive LNs were found in 18 (8.3%) cases. pN1 had significant worse OS (median: 21 vs. 41 and 56 months, <i>p</i> &#x3c; 0.001) and PFS (median:14 vs. 29 and 33 months, <i>p</i> &#x3c; 0.001) than pN0 and pNx respectively. However, survival outcomes of OS and PFS were similar between pNx-0/M1 and pN1/M0 group and between 1- and ≥2-node-positive group. Non-CCRCC (<i>p</i> = 0.001), sarcomatoid differentiation (<i>p</i> &#x3c; 0.001), and pathologically positive LNs (<i>p</i> = 0.025) were independent prognostic predictors predicting worse OS while distance metastasis (<i>p</i> = 0.009), non-CCRCC (<i>p</i> = 0.023), necrosis (<i>p</i> = 0.014), sarcomatoid differentiation (<i>p</i> = 0.003), and pathologically positive LNs (<i>p</i> = 0.007) were independent prognostic indicators predicting worse PFS. Clinically positive LNs (<i>p</i> = 0.014) and sarcomatoid differentiation (<i>p</i> = 0.009) were predictors of positive LNs. <b><i>Conclusions:</i></b> LNs metastasis independently associated with worse survival outcomes in RCC and TT populations, with similar survival outcomes compared to distance metastasis. Therefore, more accurate risk stratification is warranted for guiding postoperative surveillance and adjuvant therapy.


2008 ◽  
Vol 179 (4S) ◽  
pp. 212-212 ◽  
Author(s):  
R Houston Thompson ◽  
Ganesh V Raj ◽  
Bradley C Leibovich ◽  
Paul Russo ◽  
Michael L Blute ◽  
...  

2004 ◽  
Vol 171 (4S) ◽  
pp. 435-435
Author(s):  
Siamak Daneshmand ◽  
Shannon Tyler ◽  
Marcus L. Quek ◽  
John P. Stein ◽  
Jie Cai ◽  
...  

2004 ◽  
Vol 22 (1) ◽  
pp. 73-74
Author(s):  
A.J Pantuck ◽  
A Zisman ◽  
F Dorey ◽  
D.H Chao ◽  
K.R Han ◽  
...  

1995 ◽  
Vol 81 (6) ◽  
pp. 469-474 ◽  
Author(s):  
György Csanaky ◽  
Zoltán Szereday ◽  
Tamás Magyarlaki ◽  
Gábor Méhes ◽  
Tamás Herbert ◽  
...  

Aims and background Angiomyolipomas (AMLs) are benign hamartoid tumors which frequently occur in tuberous sclerosis (TS). They may be manifest at different organ sites such as kidneys, lymph nodes, liver and lung and may be associated with renal cell carcinoma (RCC). The nature of multiple organ involvement in AML (metastasis versus multicentric synchronous tumors), the malignant transformation and the relation of AML to RCC have not been sufficiently clarified. Study design Three cases of renal AMLs in patients with tuberous sclerosis associated with lymphangioleiomyomatosis of the paraaortic lymph nodes and/or with RCC are reported. The concise clinical history of the patients as well as the findings of histology, immunohistochemistry and quantitative DNA analysis are presented. Results The multicentric form of AML and coincidence of renal AML and RCC were observed in 2 patients. AML and RCC were found within the same focus in one of the cases. RCCs were either aneuploid or “near diploid”, whereas one of the multicentric AMLs showed a discordant DNA ploidy pattern, namely aneuploidy in the kidney and diploidy in the lymph nodes. Conclusions The presented cases (all of them underwent periaortic lymphadenectomy) suggest that lymph node involvement in renal AML may be more frequent than expected (1-2% of all AMLs) on the basis of the few reported cases. The discordant DNA ploidy (renal versus lymph node lesions) observed in one of the cases with multicentric AML implies synchronous tumor growth at different sites rather than metastatic disease. The intimate coexistance of RCC and AML (RCC revealed by immunohistochemistry within a larger mass of renal AML) may indicate that malignant transformation of an AML should only be accepted, if such a coincidence is unequivocally excluded.


Sign in / Sign up

Export Citation Format

Share Document